Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers
The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Abstract
Background Emotional processing measures are sensitive to acute administration of clinically useful antidepressant drugs. We wished to test the hypothesis that these models would also be able to detect agents likely to cause depression as an adverse effect. The anti-obesity drug and cannabinoid type 1 receptor antagonist, rimonabant, is associated with significant rates of depression and anxiety in clinical use.Materials and methods Thirty healthy adult volunteers were randomly assigned to receive a single dose of rimonabant (20 mg) or lactose placebo in a double-blind, between-groups design. Three hours after medication administration, subjects undertook an emotional processing test battery including facial emotion recognition, emotional word attentional dot probe, self-relevant word classification, emotional and declarative memory and the emotion-potentiated acoustic startle response. Subjective state was assessed via self-report measures.Results A single dose of rimonabant did not alter subjective mood. However, rimonabant selectively reduced incidental recall of positive self-relevant adjectives, an effect contrary to that seen following the administration of antidepressants. There were no effects of rimonabant on the other measures of emotional processing.Conclusions These results suggest that a single dose of rimonabant decreases positive emotional memory in the absence of changes in subjective state. Further studies are required to examine whether rimonabant might produce a wider range of negative emotional biases with repeated treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, in healthy volunteers rimonabant, after a single dose and 7 days of treatment, was shown to have an effect opposite to what would be expected of an AD drug. It reduced positive bias, decreased the number of false recollections of positive words (Horder et al. 2012), and decreased the recall of positive words, with no effect on negative words (Horder et al. 2009).”
From Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment (2021) · cites this paper as Horder et al. 2009
In the citing paper
“Further evidence to corroborate this possibility comes from studies considering the effects of the cannabinoid antiobesity agent rimonabant, which found that both single and repeated (7 days) dosing with this agent resulted in negative biases emotional memory.76,77”
From The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment (2015) · cites this paper as [77]
Citations
Cites
Ekman, P. (1976) · Medical Entomology and Zoology · Cited by 4,345
Likableness ratings of 555 personality-trait words.
Anderson, N. H. (1968) · Journal of Personality and Social Psychology · doi:10.1037/h0025907 · Cited by 1,638 · cited 1×
“domineering, untidy, hostile) or agreeable (cheerful, honest, optimistic) (taken from Anderson 1968 ) were presented on”
BackgroundEfficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Christensen, R., Kristensen, P. K., Bartels, E. M., Bliddal, H., & Astrup, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61721-8 · Cited by 1,097 · cited 1×
“However, rimonabant treatment is associated with an increased risk of both depression and anxiety (Christensen et al. 2007).”
BackgroundFear-potentiated startle: A neural and pharmacological analysis
Davis, M., Falls, W. A., Campeau, S., & Kim, M. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90102-v · Cited by 748 · cited 1×
“The enhanced startle response during a state of fear in rodents is used to assess anxiolytic properties of drugs (Davis et al. 1993).”
BackgroundFacial expression megamix: Tests of dimensional and category accounts of emotion recognition
Young, A. W., Rowland, D., Calder, A. J., Etcoff, N. L., Seth, A., & Perrett, D. I. (1997) · Cognition · doi:10.1016/s0010-0277(97)00003-6 · Cited by 539 · cited 1×
“Facial emotion recognition task The facial expression recognition task featured six basic emotions (happiness, surprise, sadness, fear, anger and disgust) taken from the Pictures of Affect Series (Ekman and Friesen 1976), which had been morphed between each prototype and neutral ( Young et al. 1997 ).”
MethodFacial emotion discrimination: II. Behavioral findings in depression
Gur, R. C., Erwin, R. J., Gur, R. E., Zwil, A. S., Heimberg, C., & Kraemer, H. C. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90116-k · Cited by 500 · cited 2×
“no effect upon other measures of emotional processing which have been associated with both antidepressant drug administration and the state of depression (Bouhuys et al. 1999; Gur et al. 1992; Harmer et al. 2003) such as facial expression recognition accuracy.”
BackgroundCognitive reactivity to sad mood provocation and the prediction of depressive relapse
Segal, Z. V., Kennedy, S., Gemar, M., Hood, K., Pedersen, R., & Buis, T. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.749 · Cited by 470 · cited 1×
“A similar reduction in memory for positive affective stimuli has also been reported in depression and has been suggested to play a significant role in the maintenance of depression as increased accessibility of negative perceptions and memories maintains and exaggerates the depressed mood (Segal et al. 2006).”
BackgroundAntidepressant Drug Treatment Modifies the Neural Processing of Nonconscious Threat Cues
Harmer, C. J., Mackay, C. E., Reid, C. B., Cowen, P. J., & Goodwin, G. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.015 · Cited by 450 · cited 1×
“This same emotional memory task is also affected by acute and repeated antidepressant drug administration in healthy volunteers: a single dose of reboxetine or duloxetine increased recall of positive emotional items in this task (Harmer et al. 2008; Harmer et al. 2006 ) contrary to the effect reported here.”
ResultSelf-citationInverse agonism and neutral antagonism at cannabinoid CB1 receptors
Pertwee, R. G. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.10.025 · Cited by 444 · cited 1×
“Rimonabant (SR141716), an antagonist and possible inverse agonist (Pertwee 2005) at cannabinoid type 1 (CB1) receptors, was licenced in the European Union for the promotion of weight loss in clinically obese patients in 2006.”
BackgroundImplicit and explicit memory for emotion-congruent information in clinical depression and anxiety
Bradley, B. P., Mogg, K., & Williams, R. (1995) · Behaviour Research and Therapy · doi:10.1016/0005-7967(95)00029-w · Cited by 291 · cited 1×
“primed lexical decision) memory paradigms (Bradley et al. 1995).”
Cited by
Neurobiological Interactions Between Stress and the Endocannabinoid System
Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.166 · Cited by 660
“…can directly potentiate stress-induced anxiety (Bergamaschi et al, 2014), promote negative memory bias (Horder et al, 2012), suppress positive memory recall (Horder et al, 2009), and dampen activation of reward circuits in the brain in response to pleasurable stimuli (Horder et al, 2010).”
BackgroundThe neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
Mayo, L. M., Asratian, A., Lindé, J., Morena, M., Haataja, R., Hammar, V., Augier, G., Hill, M. N., & Heilig, M. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.07.034 · Cited by 207
Cannabinoids and autoimmune diseases: A systematic review
Katchan, V., David, P., & Shoenfeld, Y. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.008 · Cited by 171
A cognitive neuropsychological model of antidepressant drug action
Pringle, A., Browning, M., Cowen, P. J., & Harmer, C. J. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.022 · Cited by 130
Self-citation
Metadata
- Authors
- Horder, J., Cowen, P. J., Di Simplicio, M., Browning, M., & Harmer, C. J.
- Affiliations
- Warneford Hospital (GB)
- Corresponding author
- Harmer, Catherine J.
- Venue
- Psychopharmacology
- Published
- 2009-04-01
- Volume
- 205
- Issue
- 1
- Pages
- 85-91
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2013819113
- Cited by
- 69
- References
- 20
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 7 · 2016: 2 · 2015: 12 · 2014: 3 · 2013: 7 · 2012: 5
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- rimonabant, cannabinoid CB1 receptor antagonist, emotional memory, depression, antidepressant side effects, incidental recall, facial emotion recognition, subjective mood, anti-obesity drugs
- MeSH terms
- Rimonabant, Acoustic Stimulation, Adolescent, Adult, Analysis of Variance, Dose-Response Relationship, Drug, Double-Blind Method, Emotions, Female, Humans, Male, Memory, Memory Disorders, Neuropsychological Tests, Pain Measurement, Pattern Recognition, Visual, Personality Inventory, Piperidines, Pyrazoles, Reflex, Startle, Time Factors, Verbal Learning, Recognition, Psychology, Receptor, Cannabinoid, CB1, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers. https://app.cochat.ai/papers/10.1007/s00213-009-1517-4
- The paper
- Horder, J., Cowen, P. J., Di Simplicio, M., Browning, M., & Harmer, C. J. (2009). Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers. Psychopharmacology. https://doi.org/10.1007/s00213-009-1517-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.